Subject
Psychiatry and Mental health,Clinical Psychology
Reference89 articles.
1. Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study;Boku;Hum. Psychopharmacol.,2011
2. Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression;Chen;Neuropsychiatr. Dis. Treat.,2013
3. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial;Chen;J. Clin. Psychopharmacol.,2012
4. Different forms of prefrontal theta burst stimulation for executive function of medication- resistant depression: evidence from a randomized sham-controlled study;Cheng;Prog. Neuropsychopharmacol. Biol. Psychiatry,2016
5. A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression;Fang;J. Clin. Psychopharmacol.,2011
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献